Roche at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

Roche takes part in 16 sessions at Festival of Biologics 2026 in Basel, its home city. Its sessions centre on gene therapy development, clinical trial data and the analytical testing of biologics, including mass spectrometry. Specific topics include a CAR-T cell design that a small-molecule drug switches on through the IL-12 pathway, and how to measure the potency of AAV gene therapies.

OrganizationFestival of Biologics 2026 Attendance
Roche
Basel, Switzerland
Large pharma
Swiss pharmaceutical and diagnostics company with a large biologics portfolio.
Chair
Tue Oct 13
14:05
Chair's Remarks
Regulation
Talk
Tue Oct 13
14:10
Accelerating evidence generation with collaborative research
Clinical Development & Operations
Talk
Tue Oct 13
14:30
Novel Orthogonal Receptor Platform Activating the IL12 Pathway in CAR-T Cells Using a Small-Molecule Ligand
An engineered receptor that lets a small molecule switch on interleukin-12 signalling in CAR-T cells, improving tumour killing in animal models.
Talk
Tue Oct 13
15:10
Drug Product Development for Gene Therapies
Formulation
Chair
Tue Oct 13
16:45
Chair's Remarks
Clinical Development & Operations
Talk
Tue Oct 13
17:50
Data privacy and management for trials
Clinical Development & Operations
Chair
Wed Oct 14
11:25
Chair's Remarks
AI & Computational Approaches
Talk
Wed Oct 14
11:30
Strategy for potency determination of gene therapy products illustrated by rAAV
Ways to measure whether a gene therapy made from adeno-associated virus actually works, and when an infectivity test can be skipped.
Talk
Wed Oct 14
14:30
Regulatory Reliance as a Catalyst for Biologics Access in Emerging Markets
How regulators in emerging markets can lean on reviews already done by established agencies so patients get biologic drugs sooner.
Talk
Wed Oct 14
14:50
Drug Discovery in the Era of AI
AI & Computational Approaches
Talk
Wed Oct 14
17:50
Biomarker potential of circulating methylated cfDNA signatures
Precision Medicine & Biomarkers
Chair
Thu Oct 15
11:15
Chair's Remarks
Proteomics & Mass Spectrometry
Talk
Thu Oct 15
12:00
Emerging Immunogenicity Challenges for Next-Generation Biotherapeutics
Why newer antibody drugs can trigger unwanted immune reactions that sequence checks miss, and what laboratory and animal data reveal about the causes.
Talk
Thu Oct 15
12:20
Moving away from Acetonitrile and TFA to greener eluents in Biopharma LC-MS
Proteomics & Mass Spectrometry
Talk
Thu Oct 15
12:40

Explore the full Festival of Biologics 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Roche

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction